Sensipar Sales Data
| Rank 76 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Sensipar U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 76 ( 15) |
$216,657 | 13.71% | 339 | 10.78% |
| Q3 2013 | 91 | $190,536 | 3.44% | 306 | -4.08% |
| Q2 2013 | 91 (5) |
$184,192 | 2.21% | 319 | 3.24% |
| Q1 2013 | 96 ( 4) |
$180,218 | -1.31% | 309 | -4.92% |
| Q4 2012 | 92 (5) |
$182,611 | 5.97% | 325 | 6.21% |
| Q3 2012 | 97 ( ) |
$172,317 | n/a | 306 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
